2004 to 2021 Saw Increase in Distant-Stage Breast Cancer Incidence
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 12, 2024 -- During 2004 to 2021, there was an increase in distant-stage breast cancer incidence rates at presentation, according to a study published online Dec. 10 in Radiology.
R. Edward Hendrick, Ph.D., and Debra L. Monticciolo, M.D., from the University of Colorado School of Medicine in Aurora, examined trends in distant-stage breast cancer incidence using the latest data from the Surveillance, Epidemiology, and End Results database. Stage-specific breast cancer incidence rates were analyzed from January 2004 to December 2021 in a retrospective study of 71 to 80 million women annually.
The researchers found a significant increase in distant-stage breast cancer incidence rates at presentation for U.S. women overall, with an annual percentage change (APC) of 1.16 percent during 2004 to 2021. For women aged 20 to 39 years and for women aged 75 years or older, distant-stage disease increased consistently (APCs, 2.91 and 1.44 percent, respectively). For women aged 40 to 74 years, the distant-stage breast cancer incidence rates increased with APCs of 2.10 and 2.73 percent during 2004 to 2010 and 2018 to 2021, respectively. The COVID-19-linked interruption of care in 2020 affected distant-stage breast cancer detection, especially among older women from racial and ethnic minority groups. During 2004 to 2021, the incidence of distant-stage breast cancer increased for Asian, Black, and Hispanic women (APCs, 2.90, 0.86, and 1.56 percent, respectively), and during 2004 to 2019, the incidence increased for Native American women (APC, 3.86 percent).
"Much work is needed to improve early detection and ensure that all women have sustained access to care," the authors write.
One author disclosed ties to the medical device industry.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years
FRIDAY, June 20, 2025 -- Nearly 40 percent of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy, according to a study published...
Odds of Advanced Cancer, Breast Cancer Death Lower in Screen-Detected Disease
THURSDAY, June 5, 2025 -- For patients aged 40 years or older, screen-detected breast cancer is associated with lower odds of advanced cancer, mastectomy, and breast...
Nodal Irradiation Does Not Reduce Recurrence, Death for ypN0 Breast Cancer
THURSDAY, June 5, 2025 -- For patients with node-positive breast cancer who become pathologically tumor-free with negative axillary nodes (ypN0) after neoadjuvant chemotherapy...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.